A concise, high-yield guide to cholesterol-lowering therapies—statins, Zetia, PCSK9 inhibitors, bempedoic acid, berberine, ...

Merck & Co.'s big-selling cholesterol-fighter Zetia is at the end of its exclusive road. The $2.5 billion seller now faces its first generic competitor, which threatens not only its own revenue, but ...

Despite new US cholesterol guidelines and a clinical trial that tamped down hopes that Merck’s cholesterol drug Zetia could make a difference in the rare disease space, an analysis of prescription ...

WHITEHOUSE STATION -- Shares of Whitehouse Station-based Merck rose 2.15 percent yesterday after results of a clinical trial of its cholesterol drug Zetia were not as negative as some analysts had ...

After years of uncertainty, a nearly decade-long study showed that Merck & Co's cholesterol drug Zetia lowered the risk of heart attacks and strokes in high-risk heart patients when used with an ...

NEW ORLEANS, November 8, 2004 – Results from a new study showed that coadministration of ZETIA® (ezetimibe) and fenofibrate significantly reduced LDL ("bad") cholesterol (LDL-C), non-high density ...

Q. I have hereditary high cholesterol and Type 1 diabetes. My endocrinologist was pushing me to take a statin. Because many people I know have side effects such as muscle pain, I resisted. Finally, he ...

Merck and Schering-Plough conducted several studies of their cholesterol treatment Zetia that raise questions about its risks to the liver but never published the results to those studies, The New ...

A new study casts some doubt on the benefits of Zetia, a cholesterol-lowering drug that about 1 million people in the U.S. use. The "Enhance" trial studied a combination of Zetia and the statin drug ...

CHICAGO Millions of Americans already take the drug or one of its components, Zetia. But doctors were stunned to learn that Vytorin failed to improve heart disease even though it worked as intended to ...

NEWARK (CN) - In a shareholder's class action that neatly summarizes complaints about Schering-Plough Corp.'s sales of its cholesterol drugs Zetia and Vytorin, the Arkansas Teacher Retirement System ...

CHICAGO (Reuters) - After years of uncertainty, a nearly decade-long study showed that Merck & Co's cholesterol drug Zetia lowered the risk of heart attacks and strokes in high-risk heart patients ...